Article Cited by others


Systematic review and meta-analysis on phosphodiesterase 5 inhibitors and α-adrenoceptor antagonists used alone or combined for treatment of LUTS due to BPH

Wang Xing-Huan, Wang Xiao, Shi Ming-Jun, Li Sheng, Liu Tao, Zhang Xin-Hua

Year : 2015| Volume: 17| Issue : 6 | Page no: 1022-1032

   This article has been cited by
1 Relationship between each IPSS item score and erectile dysfunction in the Korean Internet Sexuality Survey (KISS): do men with weak streams have low sexual function?
Woo Suk Choi,Won Hoon Song,Juhyun Park,Sangjun Yoo,Hwancheol Son
World Journal of Urology. 2020;
[Pubmed]  [Google Scholar] [DOI]
2 Changes in the expression and function of the PDE5 pathway in the obstructed urinary bladder
Weixiang He,Han Xiang,Daoquan Liu,Jianmin Liu,Mingzhou Li,Qian Wang,Qiaofeng Qian,Yan Li,Xun Fu,Ping Chen,Yuming Guo,Guang Zeng,Zhonghua Wu,Daxing Zhan,Xinghuan Wang,Michael E. DiSanto,Xinhua Zhang
Journal of Cellular and Molecular Medicine. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Systematic Review of Oral Combination Therapy for Erectile Dysfunction When Phosphodiesterase Type 5 Inhibitor Monotherapy Fails
Nicolai Egholt Munk,Jakob Schöllhammer Knudsen,Simon Comerma-Steffensen,Ulf Simonsen
Sexual Medicine Reviews. 2019;
[Pubmed]  [Google Scholar] [DOI]
4 Novel imaging of the prostate reveals spontaneous gland contraction and excretory duct quiescence together with different drug effects
Robert Kügler,Andrea Mietens,Mathias Seidensticker,Sabine Tasch,Florian M. Wagenlehner,Andre Kaschtanow,Yudy Tjahjono,Claudia U. Tomczyk,Daniela Beyer,Gail P. Risbridger,Betty Exintaris,Stuart J. Ellem,Ralf Middendorff
The FASEB Journal. 2018; 32(3): 1130
[Pubmed]  [Google Scholar] [DOI]
5 The BPSC: A prospective study investigating the clinical effect of interventional therapy and the risk factors for bladder cancer and benign prostatic hyperplasia in Chinese population
Xian-Tao Zeng,Tong-Zu Liu,Kan Gong,Da-Lin He,Xing-Huan Wang
Journal of Evidence-Based Medicine. 2018; 11(1): 64
[Pubmed]  [Google Scholar] [DOI]
6 Efficacy and safety of PDE5-Is and a-1 blockers for treating lower ureteric stones or LUTS: a meta-analysis of RCTs
Xifeng Sun,Wei Guan,Haoran Liu,Kun Tang,Libin Yan,Yangjun Zhang,Jin Zeng,Zhiqiang Chen,Hua Xu,Zhangqun Ye
BMC Urology. 2018; 18(1)
[Pubmed]  [Google Scholar] [DOI]
7 Alpha-blockers with or without phosphodiesterase type 5 inhibitor for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis
Jianzhong Zhang,Xiao Li,Bin Yang,Cheng Wu,Yanghua Fan,Hongjun Li
World Journal of Urology. 2018;
[Pubmed]  [Google Scholar] [DOI]
8 Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial
Sae Woong Kim,Nam Cheol Park,Seung Wook Lee,Dae Yul Yang,Jong Kwan Park,Du Geon Moon,Sang-Kuk Yang,Sung Won Lee,Ki Hak Moon,Tai Young Ahn,Soo Woong Kim,Kwangsung Park,Kweon Sik Min,Ji-Kan Ryu,Hankil Son,Jina Jung,Jae Seog Hyun
The Journal of Sexual Medicine. 2017; 14(8): 1018
[Pubmed]  [Google Scholar] [DOI]
9 Benign Prostatic Hyperplasia Treatment Options and Their Effects on Sexual Function
Igor Voznesensky,Eric Shaw,Kenneth J. DeLay,Faysal Yafi,Wayne J.G. Hellstrom
Sexual Medicine Reviews. 2016;
[Pubmed]  [Google Scholar] [DOI]


Read this article